Data compiled by Redley Lamar · ChainSifter Intelligence
9Suppliers
8Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Nautilus Biotechnology, Inc. (NAUT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
21Total relationships
3Distinct source URLs
11High confidence
0.795Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from AMGN graph: Reciprocal relationship from NAUT graph: In October 2021, we entered into a research collaboration agreement with Amgen in which the Nautilus platform may be …
GENENTECH
GENENTECH
90%
In December of 2020, we signed a research collaboration agreement with Genentech to engage in a pilot study using our technology
SINGLE-SOURCE-SUPPLIERS
SINGLE-SOURCE-SUPPLIERS
90%
The Company relies on single source suppliers for certain components and materials used in the Nautilus Voyager TM platform.
THE-BUCK-INSTITUTE-FOR-RESEARCH-ON-AGING
THE-BUCK-INSTITUTE-FOR-RESEARCH-ON-AGING
90%
In February of 2025, we entered into a research collaboration with The Buck Institute for Research on Aging where the Nautilus platform may be used across a number of projects
THE-UNIVERSITY-OF-TEXAS-MD-ANDERSON-CANCER-CENTE
THE-UNIVERSITY-OF-TEXAS-MD-ANDERSON-CANCER-CENTE
90%
In October 2021, we signed a research agreement with The University of Texas MD Anderson Cancer Center
VENDORS
VENDORS
90%
The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs.
stems will provide. We aim to build long-term loyalty with our customers by enhancing their individual research programs, enabling their successes, and driving growth within their organizations throu…
Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: stems will provide. We aim to build long-term loyalty with our customers by enhancing their individual research progra…
oyager instrument automates the Nautilus assay chemistry concurrent with rapid optical imaging of the flow cell. The current system is an early-stage design, used for optimization of the function and…
Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: oyager instrument automates the Nauti…
r; (SCIEX); Becton, Dickinson and Company; Quanterix; and Illumina, Inc. (through its acquisition of the former Somalogic business from Standard Biotools Inc.). We also compete with a number of emerg…
Reciprocal relationship from LAB graph: Reciprocal relationship from NAUT graph: r; (SCIEX); Becton, Dickinson and Company; Quanterix; and Illumina, Inc. (through its acquisition of the former Somalo…
ARYA-MAKO-MERGER-SUB-INC
ARYA-MAKO-MERGER-SUB-INC
62%
atform. During this phase, we plan to provide early access to our collaborators with broad-scale and targeted analyses and profiling of samples analyzed in our facility and shared via a cloud platfor…
ARYA-SCIENCES-ACQUISITION-CORP
ARYA-SCIENCES-ACQUISITION-CORP
62%
atform. During this phase, we plan to provide early access to our collaborators with broad-scale and targeted analyses and profiling of samples analyzed in our facility and shared via a cloud platfor…
COMPANY-LLC
COMPANY-LLC
62%
nded December 31, 2024, compared to $28.9 million for the year ended December 31, 2023, an increase of $2.1 million, or 7%. The increase was primarily due to a $0.8 increase in professional services …
DELAWARE-GENERAL-CORPORATION
DELAWARE-GENERAL-CORPORATION
62%
sters, public health crises, and other catastrophic events. For example, our San Carlos and San Diego facilities are located near earthquake fault zones and are vulnerable to damage from earthquakes …
Nautilus Biotechnology, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NAUT-DEBT-11169
Warrants outstanding: 0
90%
xbrl warrant detail from xbrl 2021-12-31.
NAUT-DEBT-11170
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-12-31.
NAUT-DEBT
Debt stack $28.9M
90%
Market cache reports total debt of $28.9M.
Nautilus Biotechnology, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Nautilus Biotechnology, Inc..
Nautilus Biotechnology, Inc. Ownership
Holder
Name
Confidence
Evidence
NAUT-OWNER-PERCEPTIVE-ADVISORS-LLC
PERCEPTIVE ADVISORS LLC
90%
13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 84 tracked holders.
Nautilus Biotechnology, Inc. Extended Supply Chain Network
